Literature DB >> 31556754

Sex differences in the inflammatory immune response to multi-walled carbon nanotubes and crystalline silica.

Jessica L Ray1, Andrij Holian1.   

Abstract

Background: Respiratory disease is a leading cause of death and disability worldwide. These diseases frequently present with a sex bias in occurrence and severity, yet the mechanisms responsible for these sex biases is a critically understudied area of basic research.
Methods: Male and female C57BL/6 mice were exposed to multi-walled carbon nanotubes (MWCNTs) or crystalline silica (cSiO2) via oropharyngeal aspiration. Acute assessments were conducted 24 h and 7 days after a single exposure. In chronic experiments, mice were exposed to respective particles once per week for 4 weeks and sacrificed 8 weeks after the last exposure. Lung lavage fluid (LLF) was assessed for markers of injury and inflammation. Immune cell populations were analyzed by flow cytometry and histopathology assessment was performed on lung tissue from chronically exposed mice.
Results: Female mice exposed to a single dose of MWCNTs generated a greater eosinophilic response than males 24 h and 7 days post-exposure. Eosinophilia was accompanied by elevated type 2 cytokine production in LLF. The exaggerated acute response in females was consistent with lung pathology observed in the chronic model: females had greater alveolitis and epithelial cell hyperplasia compared to males. There were no sex differences 24 h after cSiO2 exposure, but by 7-day post-exposure female mice had greater airspace neutrophilia and inflammatory cytokine levels compared to males. However, following repeated exposure to cSiO2, male mice had worse alveolitis and greater dendritic cell presence within the lungs. Conclusions: Female mice are more susceptible to acute and chronic MWCNT-induced inflammation, but male mice are more susceptible to chronic cSiO2-induced lung pathology.

Entities:  

Keywords:  Multi-walled carbon nanotubes; crystalline silica; eosinophils; lung inflammation; sex differences

Mesh:

Substances:

Year:  2019        PMID: 31556754      PMCID: PMC6813775          DOI: 10.1080/08958378.2019.1669743

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  48 in total

1.  Gender influences the response to experimental silica-induced lung fibrosis in mice.

Authors:  David M Brass; Sean P McGee; Mary K Dunkel; Sarah M Reilly; Jacob M Tobolewski; Tara Sabo-Attwood; Cheryl L Fattman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

2.  Fibrosis biomarkers in workers exposed to MWCNTs.

Authors:  Liliya M Fatkhutdinova; Timur O Khaliullin; Olga L Vasil'yeva; Ramil R Zalyalov; Ilshat G Mustafin; Elena R Kisin; M Eileen Birch; Naveena Yanamala; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-20       Impact factor: 4.219

Review 3.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

4.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

Authors:  Ya-Jen Chang; Hye Young Kim; Lee A Albacker; Nicole Baumgarth; Andrew N J McKenzie; Dirk E Smith; Rosemarie H Dekruyff; Dale T Umetsu
Journal:  Nat Immunol       Date:  2011-05-29       Impact factor: 25.606

5.  IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation.

Authors:  Mariola Kurowska-Stolarska; Bartosz Stolarski; Peter Kewin; Grace Murphy; Christopher J Corrigan; Sun Ying; Nick Pitman; Ananda Mirchandani; Batika Rana; Nico van Rooijen; Malcolm Shepherd; Charlie McSharry; Iain B McInnes; Damo Xu; Foo Y Liew
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

Review 6.  Silica binding and toxicity in alveolar macrophages.

Authors:  Raymond F Hamilton; Sheetal A Thakur; Andrij Holian
Journal:  Free Radic Biol Med       Date:  2007-12-27       Impact factor: 7.376

7.  Silicosis mortality trends and new exposures to respirable crystalline silica - United States, 2001-2010.

Authors:  Ki Moon Bang; Jacek M Mazurek; John M Wood; Gretchen E White; Scott A Hendricks; Ainsley Weston
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-02-13       Impact factor: 17.586

8.  The pulmonary inflammatory response to multiwalled carbon nanotubes is influenced by gender and glutathione synthesis.

Authors:  Megan M Cartwright; Stefanie C Schmuck; Charlie Corredor; Bingbing Wang; David K Scoville; Claire R Chisholm; Hui-Wen Wilkerson; Zahra Afsharinejad; Theodor K Bammler; Jonathan D Posner; Vaithiyalingam Shutthanandan; Donald R Baer; Somenath Mitra; William A Altemeier; Terrance J Kavanagh
Journal:  Redox Biol       Date:  2016-08-21       Impact factor: 11.799

9.  Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma.

Authors:  Melissa M Bunting; Alexander M Shadie; Rylie P Flesher; Valentina Nikiforova; Linda Garthwaite; Nicodemus Tedla; Cristan Herbert; Rakesh K Kumar
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

10.  Secreted Phosphoprotein 1 and Sex-Specific Differences in Silica-Induced Pulmonary Fibrosis in Mice.

Authors:  Joseph D Latoche; Alexander Chukwuma Ufelle; Fabrizio Fazzi; Koustav Ganguly; George D Leikauf; Cheryl L Fattman
Journal:  Environ Health Perspect       Date:  2016-03-08       Impact factor: 9.031

View more
  8 in total

1.  Nanoparticle-Induced Airway Eosinophilia Is Independent of ILC2 Signaling but Associated With Sex Differences in Macrophage Phenotype Development.

Authors:  Jessica L Ray; Pam K Shaw; Britten Postma; Celine A Beamer; Andrij Holian
Journal:  J Immunol       Date:  2021-11-24       Impact factor: 5.422

2.  Dietary Docosahexaenoic Acid as a Potential Treatment for Semi-acute and Chronic Particle-Induced Pulmonary Inflammation in Balb/c Mice.

Authors:  Paige Fletcher; Raymond F Hamilton; Joseph F Rhoderick; Britten Postma; Mary Buford; James J Pestka; Andrij Holian
Journal:  Inflammation       Date:  2021-10-15       Impact factor: 4.092

3.  Sex differences in the acute and subchronic lung inflammatory responses of mice to nickel nanoparticles.

Authors:  Dorothy J You; Ho Young Lee; Alexia J Taylor-Just; Keith E Linder; James C Bonner
Journal:  Nanotoxicology       Date:  2020-08-19       Impact factor: 5.913

4.  Rapid Induction of Pulmonary Inflammation, Autoimmune Gene Expression, and Ectopic Lymphoid Neogenesis Following Acute Silica Exposure in Lupus-Prone Mice.

Authors:  Preeti S Chauhan; James G Wagner; Abby D Benninghoff; Ryan P Lewandowski; Olivia K Favor; Kathryn A Wierenga; Kristen N Gilley; Elizabeth A Ross; Jack R Harkema; James J Pestka
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 8.786

Review 5.  Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review.

Authors:  Vanessa Marques Da Silva; Manon Benjdir; Pierrick Montagne; Jean-Claude Pairon; Sophie Lanone; Pascal Andujar
Journal:  Nanomaterials (Basel)       Date:  2022-07-13       Impact factor: 5.719

6.  Therapeutic treatment of dietary docosahexaenoic acid for particle-induced pulmonary inflammation in Balb/c mice.

Authors:  Paige Fletcher; Raymond F Hamilton; Joseph F Rhoderick; Britten Postma; Mary Buford; James J Pestka; Andrij Holian
Journal:  Inflamm Res       Date:  2021-02-10       Impact factor: 6.986

7.  Quantitative Structure-Activity Relationship Models for Predicting Inflammatory Potential of Metal Oxide Nanoparticles.

Authors:  Yang Huang; Xuehua Li; Shujuan Xu; Huizhen Zheng; Lili Zhang; Jingwen Chen; Huixiao Hong; Rebecca Kusko; Ruibin Li
Journal:  Environ Health Perspect       Date:  2020-06-12       Impact factor: 9.031

Review 8.  Susceptibility Factors in Chronic Lung Inflammatory Responses to Engineered Nanomaterials.

Authors:  Dorothy J You; James C Bonner
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.